IRADIMED CORPORATION (NASDAQ:IRMD) Files An 8-K Other EventsItem 8.01 Other Events.
On October26, 2017,IRADIMED CORPORATION (the “Company”) issued a press release announcing that its 3880 Magnetic Resonance Imaging compatible patient vital signs monitor has been 510(k)cleared by the U.S. Food and Drug Administration. A copy of the Company’s press release announcing the clearance is attached hereto as Exhibit99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
Press release dated October26, 2017.
IRADIMED CORP ExhibitEX-99.1 2 a17-24510_1ex99d1.htm EX-99.1 Exhibit 99.1 IRADIMED CORPORATION Announces FDA 510(k) Clearance of MRI Compatible Patient Vital Signs Monitor Winter Springs,…To view the full exhibit click
About IRADIMED CORPORATION (NASDAQ:IRMD)
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures. MRI compatible IV infusion pump system includes the 3860+ MRI compatible IV infusion pump, single-use IV tubing sets, a non-magnetic pole and a lithium battery. In addition, it offers optional upgrade systems, including the 3865 Remote Display/Control, 3861 Side Car, Dose Error Reduction System (DERS) and SpO2 monitor.
An ad to help with our costs